Yongxin Yu

Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients

Qiao Yang, Mingjing Chen, Jiaoyang Gu et al. · Frontiers in Immunology · 2021 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Ferroptosis: a new hunter of hepatocellular carcinoma

Yulang Jiang, Yongxin Yu, Ziyang Pan et al. · Cell Death Discovery · 2024 · 50 citations · Full text

Medicine, Cell Biology, Oncology +10

The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer

Qiai You, Jianmin Wang, Yongxin Yu et al. · APOPTOSIS · 2022 · 40 citations · Full text

Medicine, Molecular Biology, Oncology +17

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC

Jianmin Wang, Pu Zhou, Xudong Wang et al. · Cell Proliferation · 2019 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis

Qiao Yang, Zihan Xu, Xiewan Chen et al. · Thoracic Cancer · 2019 · 36 citations · Full text

Medicine, Oncology, Surgery +14